Showing 1 - 7 results of 7 for search 'Catherine Abrial', query time: 0.04s
Refine Results
-
1
INSTIGO Trial: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse of Triple Negative Breast Cancer by Hugo Veyssière, Hugo Veyssière, Hugo Veyssière, Sejdi Lusho, Sejdi Lusho, Sejdi Lusho, Ioana Molnar, Ioana Molnar, Ioana Molnar, Myriam Kossai, Myriam Kossai, Maureen Bernadach, Maureen Bernadach, Catherine Abrial, Catherine Abrial, Catherine Abrial, Yannick Bidet, Yannick Bidet, Nina Radosevic-Robin, Nina Radosevic-Robin, Xavier Durando, Xavier Durando, Xavier Durando
Published 2021-06-01
Article -
2
Platelet-to-Lymphocyte Ratio Is Associated With Favorable Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Study on 120 Patients by Sejdi Lusho, Sejdi Lusho, Sejdi Lusho, Xavier Durando, Xavier Durando, Xavier Durando, Xavier Durando, Marie-Ange Mouret-Reynier, Marie-Ange Mouret-Reynier, Marie-Ange Mouret-Reynier, Marie-Ange Mouret-Reynier, Myriam Kossai, Myriam Kossai, Nathalie Lacrampe, Nathalie Lacrampe, Ioana Molnar, Ioana Molnar, Ioana Molnar, Frederique Penault-Llorca, Nina Radosevic-Robin, Nina Radosevic-Robin, Catherine Abrial, Catherine Abrial, Catherine Abrial
Published 2021-07-01
Article -
3
Patient satisfaction with radio-frequency identification (RFID) tag localization compared with wire localization for nonpalpable breast lesions: the RFID trial by Raphaël Pete, Céleste Pinard, Fanny Sirodot, Ioana Molnar, Margot Dressaire, Angeline Ginzac, Catherine Abrial, Xavier Durando, Marielle Tekath
Published 2025-01-01
Article -
4
-
5
Post-therapeutic support and rehabilitation for breast cancer women in complete remission in a thermal resort: study protocol for the PACThe Real-Life conditions observational tria... by Mélanie Godiveau, Judith Passildas, Emilie Thivat, Mélanie Casile, Céleste Pinard, Alexia Giro, Marie-Ange Mouret-Reynier, Ioana Molnar, Catherine Abrial, Claude-Eugène Bouvier, Yves-Jean Bignon, Xavier Durando
Published 2025-01-01
Article -
6
Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first‐line treatment of metastatic castration‐resistant prostate cancer by Judith Passildas‐Jahanmohan, Jean‐Christophe Eymard, Mélanie Pouget, Fabrice Kwiatkowski, Isabelle Van Praagh, Laurent Savareux, Marc Atger, Xavier Durando, Catherine Abrial, Damien Richard, Angeline Ginzac Couvé, Emilie Thivat, Brigitte Monange, Philippe Chollet, Hakim Mahammedi
Published 2021-04-01
Article -
7
Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies by Nina Radosevic-Robin, Pier Selenica, Yingjie Zhu, Helen H. Won, Michael F. Berger, Lorenzo Ferrando, Emiliano Cocco, Maud Privat, Flora Ponelle-Chachuat, Catherine Abrial, Jean-Marc Nabholtz, Frederique Penault-Llorca, Jorge S. Reis-Filho, Maurizio Scaltriti
Published 2021-09-01
Article